by Kim Engqvist | Apr 13, 2021 | In the News
The Cell & Gene Meeting is organized by the Alliance for Regenerative Medicine. This year featuring more than 90 company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas...
by Kim Engqvist | Mar 15, 2021 | In the News, Press Releases
The shareholders in Amniotics AB (publ), org. No. 559024-6558 (“Amniotics”), is hereby called to the Annual General Meeting on Thursday, April 15, 2021. View all...
by Kåre Engkilde | Nov 20, 2020 | Press Releases
Amniotics AB is the first Swedish cell therapy company to receive approval for production of an investigative ATMP in its own GMP facilities. The stem cell company Amniotics AB is taking big steps closer in treating lung diseases including COVID-19. The company has...
by Kåre Engkilde | Oct 30, 2020 | In the News
On the 27th of October 2020, Amniotics was approved to carry out activities as a Tissue Establishment by the Swedish Medical Products Agency. The authorization refers to the handling of human tissues and cells intended for the manufacture of medicinal products...
by Jan Talts | Jul 3, 2020 | In the News
The Bridge & Medicon Village arranged a #iställetföralmedalen digital event on work & health. https://altitudemeetings.se/jobb-halsa/ Amniotics CEO Kåre Engilde participated in discussions on Swedish virus research. https://vimeo.com/431809235
by Jan Talts | Jul 3, 2020 | In the News
Amniotics chairman Christer Fåhraeus was recently featured in Dagens Industri. The 25 million SEK that Amniotics now takes in venture capital will be enough to investigate the possibility of using the technology against Covid-19.”We intended to use stem cells...
by Jan Talts | Jul 3, 2020 | In the News
https://www.mediconvillage.se/sv/amniotics-featured-tv4-their-novel-source-mscs-treat-covid-19 Amniotics was recently featured in Swedish TV4, in regard to development of our cell-therapeutic for COVID-19 diseases. Studies have shown that mesenchymal stem cells can...
by Jan Talts | Jul 3, 2020 | In the News
The biotech company Amniotics has developed technologies for extracting and refining amniotic fluid stem cells for cutting-edge therapy methods. In 2020, the company will enter the clinical phase, which may lead to a breakthrough in future cell therapies....
by Kim Engqvist | Jun 22, 2020 | Press Releases
Kåre Engkilde, Chief Executive Officer, plans to present an overview of the company and provide a business update at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq. During the 30 (public...
by Jan Talts | Apr 16, 2020 | In the News
Researchers at the biotech company Amniotics in Lund has developed a lung specific stem cell for treatment of covid-19. The market for treating lung- and airway diseases is valued at 47 billion Euro. – At present, we are working day and night to finish our process...
Recent Comments